Serum inorganic phosphate level is associated with fibroblast growth factor 23 among cardiac patients with preserved renal function.
Hideaki Morita, Tomohiro Fujisaka, Shu-Ichi Fujita, Nobukazu Ishizaka
Author Information
- Hideaki Morita: Departments of Cardiology, Osaka Medical College, Osaka, Japan.
- Tomohiro Fujisaka: Departments of Cardiology, Osaka Medical College, Osaka, Japan.
- Shu-Ichi Fujita: Departments of Cardiology, Osaka Medical College, Osaka, Japan.
- Nobukazu Ishizaka: Departments of Cardiology, Osaka Medical College, Osaka, Japan.
No abstract text available.
- Hypertens Res. 2015 Jan;38(1):74-9
[PMID: 25119474]
- Am J Kidney Dis. 2001 Jan;37(1):79-83
[PMID: 11136171]
- Nat Rev Endocrinol. 2009 Nov;5(11):611-9
[PMID: 19844248]
- PLoS One. 2011;6(12 ):e29105
[PMID: 22220204]
- PLoS One. 2016 Jul 11;11(7):e0156860
[PMID: 27400031]
- Hypertens Res. 2016 Oct;39(10 ):744-751
[PMID: 27250568]
- Kidney Int. 2011 Jun;79(12):1370-8
[PMID: 21389978]
- BMC Nephrol. 2014 Sep 08;15:147
[PMID: 25200959]
- Hypertens Res. 2017 Feb;40(2):181-188
[PMID: 27682653]
Fibroblast Growth Factor-23
Fibroblast Growth Factors
Glomerular Filtration Rate
Humans
Phosphates
Phosphates
Fibroblast Growth Factors
Fibroblast Growth Factor-23